Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.5 USD | -0.92% | +0.19% | +71.63% |
May. 23 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
May. 14 | Piper Sandler Adjusts Price Target on Natera to $120 From $110, Maintains Overweight Rating | MT |
Financials (USD)
Sales 2024 * | 1.44B | Sales 2025 * | 1.68B | Capitalization | 13.33B |
---|---|---|---|---|---|
Net income 2024 * | -304M | Net income 2025 * | -144M | EV / Sales 2024 * | 8.93 x |
Net cash position 2024 * | 476M | Net cash position 2025 * | 522M | EV / Sales 2025 * | 7.63 x |
P/E ratio 2024 * |
-43.6
x | P/E ratio 2025 * |
-93.1
x | Employees | 3,288 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.8% |
Latest transcript on Natera, Inc.
1 day | -0.92% | ||
1 week | +0.19% | ||
Current month | +15.75% | ||
1 month | +21.33% | ||
3 months | +51.10% | ||
6 months | +96.72% | ||
Current year | +71.63% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Chapman
CEO | Chief Executive Officer | 45 | 10-11-30 |
Jonathan Sheena
FOU | Founder | 51 | 03-10-31 |
Founder | 51 | 03-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Healy
BRD | Director/Board Member | 59 | 14-10-31 |
Roelof Botha
BRD | Director/Board Member | 50 | 06-12-31 |
Herm Rosenman
BRD | Director/Board Member | 76 | 14-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.12% | 14 M€ | -3.15% | ||
1.06% | 2 M€ | -.--% | ||
0.40% | 0 M€ | 0.00% | - | |
0.38% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 107.5 | -0.92% | 807,727 |
24-05-22 | 108.5 | +0.23% | 735,236 |
24-05-21 | 108.3 | +1.83% | 764,269 |
24-05-20 | 106.3 | -0.14% | 1,004,003 |
24-05-17 | 106.5 | -1.88% | 938,889 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.63% | 13.33B | |
+16.49% | 83.4B | |
-29.52% | 72.11B | |
0.00% | 27.04B | |
-13.29% | 16.96B | |
+1.03% | 16.86B | |
+1.57% | 15.76B | |
+1.53% | 12.76B | |
+70.68% | 12.74B | |
+1.11% | 12.32B |
- Stock Market
- Equities
- NTRA Stock